83 related articles for article (PubMed ID: 12915128)
1. Expression and subcellular localization of Ewing sarcoma (EWS) protein is affected by the methylation process.
Belyanskaya LL; Delattre O; Gehring H
Exp Cell Res; 2003 Aug; 288(2):374-81. PubMed ID: 12915128
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Ewing sarcoma (EWS)-binding proteins: interaction with hnRNP M, U, and RNA-helicases p68/72 within protein-RNA complexes.
Pahlich S; Quero L; Roschitzki B; Leemann-Zakaryan RP; Gehring H
J Proteome Res; 2009 Oct; 8(10):4455-65. PubMed ID: 19673543
[TBL] [Abstract][Full Text] [Related]
3. Exposure on cell surface and extensive arginine methylation of ewing sarcoma (EWS) protein.
Belyanskaya LL; Gehrig PM; Gehring H
J Biol Chem; 2001 Jun; 276(22):18681-7. PubMed ID: 11278906
[TBL] [Abstract][Full Text] [Related]
4. Different methylation characteristics of protein arginine methyltransferase 1 and 3 toward the Ewing Sarcoma protein and a peptide.
Pahlich S; Bschir K; Chiavi C; Belyanskaya L; Gehring H
Proteins; 2005 Oct; 61(1):164-75. PubMed ID: 16044463
[TBL] [Abstract][Full Text] [Related]
5. EWS is a substrate of type I protein arginine methyltransferase, PRMT8.
Kim JD; Kako K; Kakiuchi M; Park GG; Fukamizu A
Int J Mol Med; 2008 Sep; 22(3):309-15. PubMed ID: 18698489
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of the nuclear localization/retention signal in the EWS proto-oncoprotein.
Zakaryan RP; Gehring H
J Mol Biol; 2006 Oct; 363(1):27-38. PubMed ID: 16965792
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional down-regulation through nuclear exclusion of EWS methylated by PRMT1.
Araya N; Hiraga H; Kako K; Arao Y; Kato S; Fukamizu A
Biochem Biophys Res Commun; 2005 Apr; 329(2):653-60. PubMed ID: 15737635
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism.
Anumanthan G; Halder SK; Friedman DB; Datta PK
Cancer Res; 2006 Nov; 66(22):10824-32. PubMed ID: 17108118
[TBL] [Abstract][Full Text] [Related]
9. Adipogenesis stimulates the nuclear localization of EWS with an increase in its O-GlcNAc glycosylation in 3T3-L1 cells.
Li Q; Kamemura K
Biochem Biophys Res Commun; 2014 Jul; 450(1):588-92. PubMed ID: 24928395
[TBL] [Abstract][Full Text] [Related]
10. Dynamic subcellular localization of the Ewing sarcoma proto-oncoprotein and its association with and stabilization of microtubules.
Leemann-Zakaryan RP; Pahlich S; Sedda MJ; Quero L; Grossenbacher D; Gehring H
J Mol Biol; 2009 Feb; 386(1):1-13. PubMed ID: 19133275
[TBL] [Abstract][Full Text] [Related]
11. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting.
Theisen ER; Pishas KI; Saund RS; Lessnick SL
Oncotarget; 2016 Apr; 7(14):17616-30. PubMed ID: 26848860
[TBL] [Abstract][Full Text] [Related]
13. EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma.
Cidre-Aranaz F; Grünewald TG; Surdez D; García-García L; Carlos Lázaro J; Kirchner T; González-González L; Sastre A; García-Miguel P; López-Pérez SE; Monzón S; Delattre O; Alonso J
Oncogene; 2017 Feb; 36(6):766-776. PubMed ID: 27375017
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
Fukuma M; Okita H; Hata J; Umezawa A
Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
[TBL] [Abstract][Full Text] [Related]
15. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
[TBL] [Abstract][Full Text] [Related]
16. Participation of nuclear localization signal 2 in the 3'-ETS domain of FLI1 in nuclear translocation of various chimeric EWS-FLI1 oncoproteins in Ewing tumor.
Honsei N; Ikuta T; Kawana K; Kaneko Y; Kawajiri K
Int J Oncol; 2006 Sep; 29(3):689-93. PubMed ID: 16865286
[TBL] [Abstract][Full Text] [Related]
17. Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state.
Pahlich S; Zakaryan RP; Gehring H
Proteins; 2008 Sep; 72(4):1125-37. PubMed ID: 18320585
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of the EWS oncogene transcriptional activation domain.
Ng KP; Li KK; Lee KA
Biochemistry; 2009 Apr; 48(13):2849-57. PubMed ID: 19290668
[TBL] [Abstract][Full Text] [Related]
19. The RGG domain in hnRNP A2 affects subcellular localization.
Nichols RC; Wang XW; Tang J; Hamilton BJ; High FA; Herschman HR; Rigby WF
Exp Cell Res; 2000 May; 256(2):522-32. PubMed ID: 10772824
[TBL] [Abstract][Full Text] [Related]
20. [Construction of recombinant adenoviral vector containing gene of EWS-FLI1 and antitumor immunity of its modified dentritic cell in vitro].
Qu HY; Guo W; He XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 38(6):623-7. PubMed ID: 17173084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
